InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Treco Douglas A. Director active across 1 company, notably Inozyme Pharma, Inc.. Aggregated, 3 reports have been recorded. Activity tracked since 30 September 2024. The latest transaction was filed on 30 September 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations